Biogen Inc.
DE ˙ DB ˙ US09062X1037
170,90 € ↑8,70 (5,36%)
2026-06-04
CENA AKCJI
SecurityDE:IDP / Biogen Inc.
InstitutionFifth Third Bancorp
Latest Disclosed Ownership32,716 shares
Latest Disclosed Value $ 5,997,778
Fifth Third Bancorp reports 255.15% increase in ownership of IDP / Biogen Inc.

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 32,716 shares of Biogen Inc. (DE:IDP) valued at $5,079,159 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 9,212 shares of Biogen Inc.. This represents a change in shares of 255.15% during the quarter. The current value of the position is $5,591,164 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F BIOGEN COM 09062X103 32,716 23,504 255.15 5,998 269.96 0.0110
2026-02-02 2025-12-31 13F BIOGEN COM 09062X103 9,212 202 2.24 1,621 28.45 0.0051
2025-11-07 2025-09-30 13F BIOGEN COM 09062X103 9,010 1,633 22.14 1,262 36.29 0.0040
2025-07-15 2025-06-30 13F BIOGEN COM 09062X103 7,377 1,888 34.40 926 23.30 0.0032
2025-04-15 2025-03-31 13F BIOGEN COM 09062X103 5,489 2,243 69.10 751 51.41 0.0029
2025-01-21 2024-12-31 13F BIOGEN COM 09062X103 3,246 -113 -3.36 496 -23.81 0.0018
2024-10-17 2024-09-30 13F BIOGEN COM 09062X103 3,359 -177 -5.01 651 -20.51 0.0024
2024-07-22 2024-06-30 13F BIOGEN COM 09062X103 3,536 551 18.46 820 27.37 0.0031
2024-04-23 2024-03-31 13F BIOGEN COM 09062X103 2,985 -135 -4.33 644 -20.32 0.0025
2024-01-19 2023-12-31 13F BIOGEN COM 09062X103 3,120 -131 -4.03 807 -3.35 0.0034
2023-10-31 2023-09-30 13F BIOGEN COM 09062X103 3,251 -704 -17.80 836 -25.84 0.0039
2023-07-26 2023-06-30 13F BIOGEN COM 09062X103 3,955 48 1.23 1,127 3.68 0.0050
2023-04-24 2023-03-31 13F BIOGEN COM 09062X103 3,907 542 16.11 1,086 16.65 0.0051
2023-01-25 2022-12-31 13F BIOGEN COM 09062X103 3,365 384 12.88 932 16.96 0.0045
2022-10-25 2022-09-30 13F BIOGEN COM 09062X103 2,981 -77 -2.52 796 27.56 0.0042
2022-08-04 2022-06-30 13F BIOGEN COM 09062X103 3,058 -224 -6.83 624 -9.70 0.0030
2022-04-19 2022-03-31 13F BIOGEN COM 09062X103 3,282 -6,002 -64.65 691 -68.97 0.0028
2022-02-01 2021-12-31 13F BIOGEN COM 09062X103 9,284 -1,843 -16.56 2,227 -29.28 0.0087
2021-10-15 2021-09-30 13F BIOGEN COM 09062X103 11,127 -6,220 -35.86 3,149 -47.58 0.0137
2021-08-06 2021-06-30 13F BIOGEN COM 09062X103 17,347 -4,217 -19.56 6,007 -0.43 0.0264
2021-05-07 2021-03-31 13F BIOGEN COM 09062X103 21,564 -2,151 -9.07 6,033 3.89 0.0280
2021-02-16 2020-12-31 13F BIOGEN COM 09062X103 23,715 -2,606 -9.90 5,807 -22.23 0.0285
2020-11-09 2020-09-30 13F BIOGEN COM 09062X103 26,321 -2,230 -7.81 7,467 -2.25 0.0413
2020-08-05 2020-06-30 13F BIOGEN COM 09062X103 28,551 -1,131 -3.81 7,639 -18.66 0.0458
2020-05-05 2020-03-31 13F BIOGEN COM 09062X103 29,682 -5,885 -16.55 9,391 -11.02 0.0670
2020-02-14 2019-12-31 13F BIOGEN COM 09062X103 35,567 -9,544 -21.16 10,554 0.49 0.0588
2019-11-14 2019-09-30 13F BIOGEN COM 09062X103 45,111 -15,539 -25.62 10,503 -25.95 0.0630
2019-08-07 2019-06-30 13F BIOGEN COM 09062X103 60,650 -2,654 -4.19 14,184 -5.21 0.0867
2019-05-14 2019-03-31 13F BIOGEN COM 09062X103 63,304 -9,469 -13.01 14,964 -31.67 0.0960
2019-02-14 2018-12-31 13F BIOGEN COM 09062X103 72,773 -15,005 -17.09 21,899 -29.39 0.1592
2018-11-14 2018-09-30 13F BIOGEN COM 09062X103 87,778 9,522 12.17 31,013 36.54 0.1973
2018-08-14 2018-06-30 13F BIOGEN COM 09062X103 78,256 138 0.18 22,713 6.19 0.1540
2018-05-15 2018-03-31 13F BIOGEN COM 09062X103 78,118 4,828 6.59 21,390 -8.39 0.1457
2018-02-14 2017-12-31 13F BIOGEN COM 09062X103 73,290 -2,368 -3.13 23,348 -1.44 0.1588
2017-11-14 2017-09-30 13F BIOGEN COM 09062X103 75,658 -871 -1.14 23,690 14.08 0.1695
2017-08-11 2017-06-30 13F BIOGEN COM 09062X103 76,529 -11,235 -12.80 20,767 -13.46 0.1529
2017-05-12 2017-03-31 13F BIOGEN COM 09062X103 87,764 -3,170 -3.49 23,996 -6.95 0.1814
2017-02-13 2016-12-31 13F/A-1 BIOGEN COM 09062X103 90,934 379 0.42 25,787 -9.03 0.2080
2017-02-09 2016-12-31 13F BIOGEN COM 09062X103 90,555 0 28,346 0.2346
2016-11-10 2016-09-30 13F BIOGEN COM 09062X103 90,555 -390 -0.43 28,346 28.89 0.2346
2016-08-11 2016-06-30 13F BIOGEN COM 09062X103 90,945 130 0.14 21,992 -6.98 0.1868
2016-05-13 2016-03-31 13F BIOGEN COM 09062X103 90,815 -2,872 -3.07 23,641 -17.63 0.2046
2016-02-16 2015-12-31 13F BIOGEN COM 09062X103 93,687 -2,046 -2.14 28,701 2.74 0.2520
2015-11-13 2015-09-30 13F BIOGEN COM 09062X103 95,733 9,462 10.97 27,936 -19.83 0.2592
2015-08-14 2015-06-30 13F BIOGEN COM 09062X103 86,271 12,901 17.58 34,848 12.49 0.3039
2015-05-14 2015-03-31 13F BIOGEN COM 09062X103 73,370 4,911 7.17 30,980 33.32 0.2681
2015-02-13 2014-12-31 13F BIOGEN IDEC COM 09062X103 68,459 30,578 80.72 23,238 85.44 0.1985
2014-11-17 2014-09-30 13F BIOGEN IDEC COM 09062X103 37,881 9,218 32.16 12,531 38.65 0.1142
2014-08-14 2014-06-30 13F BIOGEN IDEC COM 09062X103 28,663 12,486 77.18 9,038 82.66 0.0818
2014-05-15 2014-03-31 13F BIOGEN IDEC COM 09062X103 16,177 12,170 303.72 4,948 341.79 0.0465
2014-02-14 2013-12-31 13F BIOGEN IDEC COM 09062X103 4,007 -512 -11.33 1,120 2.94 0.0108
2013-11-14 2013-09-30 13F BIOGEN IDEC COM 09062X103 4,519 -1,061 -19.01 1,088 -9.41 0.0112
2013-08-14 2013-06-30 13F BIOGEN IDEC COM 09062X103 5,580 5,580 1,201 0.0128
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.